id	sid	eid	entity	type
ajlm-1807	1	1	oluwalana t. oyekale department of medical	ORG
ajlm-1807	1	2	afe babalola university	ORG
ajlm-1807	1	3	ado ekiti	ORG
ajlm-1807	1	4	nigeria department of medical	ORG
ajlm-1807	1	5	ido	ORG
ajlm-1807	1	6	nigeria bola o. ojo department of medical	ORG
ajlm-1807	1	7	ido	ORG
ajlm-1807	1	8	nigeria	GPE
ajlm-1807	1	9	adewale t. olajide department	PERSON
ajlm-1807	1	10	afe babalola university	ORG
ajlm-1807	1	11	ado ekiti	ORG
ajlm-1807	1	12	nigeria department	ORG
ajlm-1807	1	13	ido	ORG
ajlm-1807	1	14	nigeria	GPE
ajlm-1807	1	15	i. oyekale department	ORG
ajlm-1807	1	16	ido	ORG
ajlm-1807	1	17	nigeria	GPE
ajlm-1807	1	18	nigeria	GPE
ajlm-1807	2	1	afr j	PERSON
ajlm-1807	3	1	2022;11(1	CARDINAL
ajlm-1807	4	1	nigeria	GPE
ajlm-1807	4	2	t. oyekale	GPE
ajlm-1807	4	3	bola o. ojo	ORG
ajlm-1807	4	4	adewale t. olajide	PERSON
ajlm-1807	4	5	i. oyekale	PERSON
ajlm-1807	4	6	01	CARDINAL
ajlm-1807	4	7	dec. 2021	DATE
ajlm-1807	4	8	25	CARDINAL
ajlm-1807	4	9	2022	CARDINAL
ajlm-1807	4	10	24	CARDINAL
ajlm-1807	4	11	2022	CARDINAL
ajlm-1807	4	12	2022	CARDINAL
ajlm-1807	10	1	bsi	ORG
ajlm-1807	11	1	ido	ORG
ajlm-1807	11	2	nigeria	GPE
ajlm-1807	11	3	between june 2020	DATE
ajlm-1807	11	4	february 2021	DATE
ajlm-1807	11	5	177	CARDINAL
ajlm-1807	11	6	bsi	ORG
ajlm-1807	13	1	19.2%	PERCENT
ajlm-1807	14	1	0.97	CARDINAL
ajlm-1807	15	1	gram	CARDINAL
ajlm-1807	15	2	67.6%	PERCENT
ajlm-1807	15	3	29.4%	PERCENT
ajlm-1807	15	4	20.6%	PERCENT
ajlm-1807	16	1	23.5%	PERCENT
ajlm-1807	17	1	three	CARDINAL
ajlm-1807	17	2	37.5%	PERCENT
ajlm-1807	18	1	meropenem	GPE
ajlm-1807	18	2	97.1%	PERCENT
ajlm-1807	18	3	ceftazidime	PERSON
ajlm-1807	18	4	85.3%	PERCENT
ajlm-1807	18	5	79.4%	PERCENT
ajlm-1807	18	6	ofloxacin	PERSON
ajlm-1807	18	7	79.4%	PERCENT
ajlm-1807	18	8	76.5%	PERCENT
ajlm-1807	19	1	32.4%	PERCENT
ajlm-1807	19	2	38.2%	PERCENT
ajlm-1807	20	1	gram	CARDINAL
ajlm-1807	20	2	s. aureus	PERSON
ajlm-1807	25	1	up to 9% – 11%	PERCENT
ajlm-1807	25	2	europe	LOC
ajlm-1807	25	3	the united states	GPE
ajlm-1807	25	4	up to 19%	PERCENT
ajlm-1807	25	5	european	NORP
ajlm-1807	25	6	bsi	ORG
ajlm-1807	25	7	an additional 6.0–11.5 days	DATE
ajlm-1807	25	8	bsi	ORG
ajlm-1807	25	9	8000	MONEY
ajlm-1807	25	10	united states dollars (	ORG
ajlm-1807	25	11	$56 000	MONEY
ajlm-1807	25	12	4.0%	PERCENT
ajlm-1807	25	13	41.5%	PERCENT
ajlm-1807	26	1	bsi	ORG
ajlm-1807	26	2	9.2%	PERCENT
ajlm-1807	26	3	44.0%	PERCENT
ajlm-1807	27	1	nigeria	GPE
ajlm-1807	27	2	bsi	ORG
ajlm-1807	27	3	nigeria	GPE
ajlm-1807	28	1	iregbu et al.	PERSON
ajlm-1807	28	2	nigeria	GPE
ajlm-1807	28	3	19.0%	PERCENT
ajlm-1807	28	4	22.0%	PERCENT
ajlm-1807	28	5	35.0%	PERCENT
ajlm-1807	28	6	gram	CARDINAL
ajlm-1807	30	1	gram	CARDINAL
ajlm-1807	31	1	enterococcus spp.13,14	ORG
ajlm-1807	33	1	carbapenem	PERSON
ajlm-1807	33	2	gram	CARDINAL
ajlm-1807	33	3	mrsa.17	GPE
ajlm-1807	33	4	gram	CARDINAL
ajlm-1807	34	1	the past years	DATE
ajlm-1807	35	1	bsi	ORG
ajlm-1807	38	1	ido	ORG
ajlm-1807	38	2	nigeria	GPE
ajlm-1807	42	1	the department of medical microbiology	ORG
ajlm-1807	42	2	ido	ORG
ajlm-1807	42	3	nigerian	NORP
ajlm-1807	43	1	nigeria	GPE
ajlm-1807	44	1	290	CARDINAL
ajlm-1807	45	1	177	CARDINAL
ajlm-1807	45	2	177	CARDINAL
ajlm-1807	45	3	between june 2020	DATE
ajlm-1807	45	4	february 2021	DATE
ajlm-1807	47	1	two	CARDINAL
ajlm-1807	47	2	two	CARDINAL
ajlm-1807	47	3	30 minutes	TIME
ajlm-1807	47	4	bsi	ORG
ajlm-1807	48	1	8 ml	QUANTITY
ajlm-1807	48	2	10 ml	QUANTITY
ajlm-1807	48	3	2 ml	QUANTITY
ajlm-1807	48	4	2 ml	QUANTITY
ajlm-1807	48	5	5 ml	QUANTITY
ajlm-1807	49	1	biomérieux, inc.	ORG
ajlm-1807	49	2	durham	GPE
ajlm-1807	49	3	north carolina	GPE
ajlm-1807	49	4	united states	GPE
ajlm-1807	50	1	3d	CARDINAL
ajlm-1807	50	2	biomérieux, inc.	ORG
ajlm-1807	50	3	durham	GPE
ajlm-1807	50	4	north caroline	GPE
ajlm-1807	50	5	united states	GPE
ajlm-1807	51	1	oxoid	ORG
ajlm-1807	51	2	basingstoke	ORG
ajlm-1807	51	3	united kingdom	GPE
ajlm-1807	51	4	macconkey	PERSON
ajlm-1807	51	5	oxoid	ORG
ajlm-1807	51	6	basingstoke	ORG
ajlm-1807	51	7	united kingdom	GPE
ajlm-1807	52	1	macconkey	PERSON
ajlm-1807	52	2	days 2, 5	DATE
ajlm-1807	52	3	7	CARDINAL
ajlm-1807	53	1	37 °	QUANTITY
ajlm-1807	53	2	18 hours	TIME
ajlm-1807	53	3	24 hours	TIME
ajlm-1807	54	1	gram	CARDINAL
ajlm-1807	54	2	mueller-hinton	ORG
ajlm-1807	54	3	oxoid	ORG
ajlm-1807	54	4	basingstoke	ORG
ajlm-1807	54	5	united kingdom	GPE
ajlm-1807	54	6	kirby-bauer	ORG
ajlm-1807	55	1	imipenem	PERSON
ajlm-1807	55	2	10 μg	CARDINAL
ajlm-1807	55	3	meropenem	GPE
ajlm-1807	55	4	10 μg	CARDINAL
ajlm-1807	55	5	20/10	CARDINAL
ajlm-1807	55	6	10 μg	CARDINAL
ajlm-1807	55	7	5 μg	CARDINAL
ajlm-1807	55	8	cefriaxone	GPE
ajlm-1807	55	9	30	CARDINAL
ajlm-1807	55	10	30 μg	CARDINAL
ajlm-1807	55	11	20/10	CARDINAL
ajlm-1807	55	12	5 μg	CARDINAL
ajlm-1807	55	13	10 μg	CARDINAL
ajlm-1807	56	1	oxoid	ORG
ajlm-1807	56	2	basingstoke	ORG
ajlm-1807	56	3	united kingdom	GPE
ajlm-1807	57	1	gram	CARDINAL
ajlm-1807	57	2	30	CARDINAL
ajlm-1807	57	3	30/10	CARDINAL
ajlm-1807	57	4	biomérieux, inc.	ORG
ajlm-1807	57	5	durham	GPE
ajlm-1807	57	6	north carolina	GPE
ajlm-1807	57	7	united states	GPE
ajlm-1807	58	1	bsi	ORG
ajlm-1807	59	1	microsoft	ORG
ajlm-1807	59	2	2017	CARDINAL
ajlm-1807	59	3	microsoft corporation	ORG
ajlm-1807	59	4	redmond	GPE
ajlm-1807	59	5	washington	GPE
ajlm-1807	59	6	united states	GPE
ajlm-1807	59	7	20.0	CARDINAL
ajlm-1807	59	8	ibm corp.	ORG
ajlm-1807	59	9	armonk	GPE
ajlm-1807	59	10	new york	GPE
ajlm-1807	59	11	united states	GPE
ajlm-1807	61	1	fisher	ORG
ajlm-1807	63	1	4 days to	DATE
ajlm-1807	63	2	87 years	DATE
ajlm-1807	63	3	23.29 ±	PERCENT
ajlm-1807	63	4	26.58 years	DATE
ajlm-1807	63	5	1	CARDINAL
ajlm-1807	64	1	177	CARDINAL
ajlm-1807	64	2	102	CARDINAL
ajlm-1807	64	3	57.6%	PERCENT
ajlm-1807	64	4	75	DATE
ajlm-1807	64	5	42.4%	PERCENT
ajlm-1807	65	1	27	CARDINAL
ajlm-1807	65	2	26.5%	PERCENT
ajlm-1807	65	3	15	CARDINAL
ajlm-1807	65	4	20.0%	PERCENT
ajlm-1807	65	5	the age of one month	DATE
ajlm-1807	65	6	15	CARDINAL
ajlm-1807	65	7	14.7%	PERCENT
ajlm-1807	65	8	23	CARDINAL
ajlm-1807	65	9	30.7%	PERCENT
ajlm-1807	65	10	older than 50 years	DATE
ajlm-1807	66	1	1	CARDINAL
ajlm-1807	66	2	ido	ORG
ajlm-1807	66	3	nigeria	GPE
ajlm-1807	66	4	between june 2020	DATE
ajlm-1807	66	5	february 2021	DATE
ajlm-1807	67	1	only 34	CARDINAL
ajlm-1807	67	2	19.2%	PERCENT
ajlm-1807	67	3	2	CARDINAL
ajlm-1807	68	1	1 month	DATE
ajlm-1807	68	2	23.8%	PERCENT
ajlm-1807	68	3	6–17 years	DATE
ajlm-1807	68	4	12.9%	PERCENT
ajlm-1807	69	1	20.0%	PERCENT
ajlm-1807	69	2	9.5%	PERCENT
ajlm-1807	69	3	6–17 years	DATE
ajlm-1807	69	4	0.57	CARDINAL
ajlm-1807	70	1	0.97	CARDINAL
ajlm-1807	71	1	2	CARDINAL
ajlm-1807	71	2	ido	ORG
ajlm-1807	71	3	nigeria	GPE
ajlm-1807	71	4	between june 2020	DATE
ajlm-1807	71	5	february 2021	DATE
ajlm-1807	72	1	e. coli	PERSON
ajlm-1807	72	2	10/34	CARDINAL
ajlm-1807	72	3	29.4%	PERCENT
ajlm-1807	72	4	s. aureus	PERSON
ajlm-1807	72	5	8/34	CARDINAL
ajlm-1807	72	6	23.5%	PERCENT
ajlm-1807	72	7	k. aerogenes	PERSON
ajlm-1807	72	8	7/34	DATE
ajlm-1807	72	9	20.6%	PERCENT
ajlm-1807	72	10	3	CARDINAL
ajlm-1807	73	1	gram	CARDINAL
ajlm-1807	73	2	23/34	CARDINAL
ajlm-1807	73	3	67.6%	PERCENT
ajlm-1807	73	4	4	CARDINAL
ajlm-1807	74	1	gram	CARDINAL
ajlm-1807	74	2	1 month	DATE
ajlm-1807	74	3	8/42	CARDINAL
ajlm-1807	74	4	19.0%	PERCENT
ajlm-1807	74	5	older than one month	DATE
ajlm-1807	74	6	15/135	CARDINAL
ajlm-1807	74	7	11.1%	PERCENT
ajlm-1807	74	8	0.18	CARDINAL
ajlm-1807	75	1	10/42	CARDINAL
ajlm-1807	75	2	23.8%	PERCENT
ajlm-1807	75	3	older than one month	DATE
ajlm-1807	75	4	17.8%	PERCENT
ajlm-1807	75	5	0.39	CARDINAL
ajlm-1807	76	1	3	CARDINAL
ajlm-1807	76	2	ido	ORG
ajlm-1807	76	3	nigeria	GPE
ajlm-1807	76	4	between june 2020	DATE
ajlm-1807	76	5	february 2021	DATE
ajlm-1807	77	1	4	CARDINAL
ajlm-1807	77	2	gram	CARDINAL
ajlm-1807	77	3	gram	CARDINAL
ajlm-1807	77	4	ido	ORG
ajlm-1807	77	5	nigeria	GPE
ajlm-1807	77	6	between june 2020	DATE
ajlm-1807	77	7	february 2021	DATE
ajlm-1807	78	1	100.0%	PERCENT
ajlm-1807	78	2	meropenem	GPE
ajlm-1807	78	3	33/34	CARDINAL
ajlm-1807	78	4	97.1%	PERCENT
ajlm-1807	78	5	imipenem	GPE
ajlm-1807	78	6	29/34	CARDINAL
ajlm-1807	78	7	85.3%	PERCENT
ajlm-1807	78	8	27/34	CARDINAL
ajlm-1807	78	9	79.4%	PERCENT
ajlm-1807	78	10	26/34	CARDINAL
ajlm-1807	78	11	76.5%	PERCENT
ajlm-1807	78	12	5	CARDINAL
ajlm-1807	79	1	11/34	CARDINAL
ajlm-1807	79	2	32.4%	PERCENT
ajlm-1807	79	3	13/34	CARDINAL
ajlm-1807	79	4	38.2%	PERCENT
ajlm-1807	80	1	gram	CARDINAL
ajlm-1807	81	1	three	CARDINAL
ajlm-1807	81	2	37.5%	PERCENT
ajlm-1807	81	3	eight	CARDINAL
ajlm-1807	82	1	3/3	CARDINAL
ajlm-1807	82	2	100%	PERCENT
ajlm-1807	82	3	s. aureus	PERSON
ajlm-1807	82	4	8/8	CARDINAL
ajlm-1807	82	5	100%	PERCENT
ajlm-1807	83	1	5	CARDINAL
ajlm-1807	83	2	ido	ORG
ajlm-1807	83	3	nigeria	GPE
ajlm-1807	83	4	between june 2020	DATE
ajlm-1807	83	5	february 2021	DATE
ajlm-1807	84	1	19.2%	PERCENT
ajlm-1807	85	1	deku et al	PERSON
ajlm-1807	85	2	13.1%	PERCENT
ajlm-1807	85	3	ghana	GPE
ajlm-1807	85	4	gupta et al.	PERSON
ajlm-1807	85	5	16.5%	PERCENT
ajlm-1807	86	1	10.3%	PERCENT
ajlm-1807	86	2	9.2%	PERCENT
ajlm-1807	86	3	bsi	ORG
ajlm-1807	86	4	44.0%	PERCENT
ajlm-1807	86	5	khanal et al	ORG
ajlm-1807	87	1	india.9	GPE
ajlm-1807	87	2	nigeria	GPE
ajlm-1807	87	3	africa	LOC
ajlm-1807	88	1	23.8%	PERCENT
ajlm-1807	89	1	19.0%	PERCENT
ajlm-1807	89	2	iregbu et al	ORG
ajlm-1807	90	1	22.0%	PERCENT
ajlm-1807	91	1	nigeria	GPE
ajlm-1807	91	2	sorsa	ORG
ajlm-1807	91	3	ethiopia	GPE
ajlm-1807	91	4	29.3%	PERCENT
ajlm-1807	92	1	uzodimma et al.	GPE
ajlm-1807	93	1	nigeria	GPE
ajlm-1807	93	2	35.0%	PERCENT
ajlm-1807	93	3	el-din et al	PERSON
ajlm-1807	94	1	egypt	GPE
ajlm-1807	94	2	40.7%).10,11,12,26,27	CARDINAL
ajlm-1807	95	1	bsi	ORG
ajlm-1807	95	2	bsi	ORG
ajlm-1807	96	1	gram	CARDINAL
ajlm-1807	96	2	67.6%	PERCENT
ajlm-1807	96	3	e. coli	PERSON
ajlm-1807	96	4	29.4%	PERCENT
ajlm-1807	97	1	23.5%	PERCENT
ajlm-1807	97	2	8.8%	PERCENT
ajlm-1807	98	1	gram	CARDINAL
ajlm-1807	98	2	s. aureus	PERSON
ajlm-1807	98	3	bsi.15,23,25,29,30,31	PERSON
ajlm-1807	98	4	bsi	ORG
ajlm-1807	99	1	gram	CARDINAL
ajlm-1807	99	2	the 1950s	DATE
ajlm-1807	99	3	gram	CARDINAL
ajlm-1807	99	4	the 1960s to 1980s	DATE
ajlm-1807	100	1	the 1980s	DATE
ajlm-1807	100	2	gram	CARDINAL
ajlm-1807	100	3	more than 50%	PERCENT
ajlm-1807	100	4	sepsis.32,33	PRODUCT
ajlm-1807	100	5	gram	CARDINAL
ajlm-1807	101	1	gram	CARDINAL
ajlm-1807	102	1	gram	CARDINAL
ajlm-1807	102	2	sorsa	ORG
ajlm-1807	102	3	el-din et al	PERSON
ajlm-1807	103	1	gram	CARDINAL
ajlm-1807	104	1	iregbu	NORP
ajlm-1807	104	2	gram	CARDINAL
ajlm-1807	104	3	gram	CARDINAL
ajlm-1807	104	4	abuja	GPE
ajlm-1807	104	5	s. aureus	PERSON
ajlm-1807	104	6	three	CARDINAL
ajlm-1807	106	1	meropenem	GPE
ajlm-1807	106	2	97.1%	PERCENT
ajlm-1807	107	1	85.3%	PERCENT
ajlm-1807	107	2	ofloxacin	PERSON
ajlm-1807	107	3	79.4%	PERCENT
ajlm-1807	107	4	79.4%	PERCENT
ajlm-1807	107	5	76.5%	PERCENT
ajlm-1807	108	1	32.4%	PERCENT
ajlm-1807	108	2	38.2%	PERCENT
ajlm-1807	108	3	amoxycillin-clavulanate	PERSON
ajlm-1807	108	4	64.7%	PERCENT
ajlm-1807	108	5	67.6%	PERCENT
ajlm-1807	108	6	ceftriaxone	GPE
ajlm-1807	108	7	67.6%	PERCENT
ajlm-1807	111	1	less than 16 years of age	DATE
ajlm-1807	112	1	three	CARDINAL
ajlm-1807	113	1	meropenem	GPE
ajlm-1807	113	2	imipenem	GPE
ajlm-1807	114	1	meropenem	GPE
ajlm-1807	114	2	imipenem	GPE
ajlm-1807	115	1	bsi	ORG
ajlm-1807	119	1	nigeria	GPE
ajlm-1807	119	2	african	NORP
ajlm-1807	120	1	gram	CARDINAL
ajlm-1807	120	2	bsi	ORG
ajlm-1807	121	1	meropenem	GPE
ajlm-1807	121	2	imipenem	GPE
ajlm-1807	129	1	four	CARDINAL
ajlm-1807	132	1	beekman se	GPE
ajlm-1807	132	2	chapin kc	PERSON
ajlm-1807	132	3	morel ka	PERSON
ajlm-1807	132	4	munson e	PERSON
ajlm-1807	134	1	j clin microbiol	PERSON
ajlm-1807	135	1	2003;41(8):3655–3660	CARDINAL
ajlm-1807	138	1	geneva	GPE
ajlm-1807	138	2	2011	DATE
ajlm-1807	138	3	2021	CARDINAL
ajlm-1807	138	4	oct 28	DATE
ajlm-1807	139	1	latour k	PERSON
ajlm-1807	140	1	two	CARDINAL
ajlm-1807	140	2	european	NORP
ajlm-1807	140	3	2016	CARDINAL
ajlm-1807	142	1	2018;23(46):1800516	CARDINAL
ajlm-1807	142	2	years	DATE
ajlm-1807	142	3	dalys	PERSON
ajlm-1807	142	4	europe	LOC
ajlm-1807	142	5	european union	ORG
ajlm-1807	142	6	european	NORP
ajlm-1807	142	7	2009	DATE
ajlm-1807	142	8	2013	DATE
ajlm-1807	144	1	2018;23:17-00454	CARDINAL
ajlm-1807	145	1	bevin	PERSON
ajlm-1807	145	2	jianfang l	PERSON
ajlm-1807	145	3	elaine l.	PERSON
ajlm-1807	147	1	2018;19(1):37–42	CARDINAL
ajlm-1807	148	1	https://doi.org/10.1177/1757177417720998	DATE
ajlm-1807	151	1	2014;5(1):57–65	CARDINAL
ajlm-1807	152	1	landini mp	PERSON
ajlm-1807	152	2	sambri	PERSON
ajlm-1807	156	1	sabnis	ORG
ajlm-1807	156	2	desai m. bacteriological	PERSON
ajlm-1807	157	1	2014;2014:153747	CARDINAL
ajlm-1807	157	2	https://doi.org/10.1155/2014/153747 khanal b	ORG
ajlm-1807	157	3	harish bn	ORG
ajlm-1807	157	4	kr	ORG
ajlm-1807	157	5	srinivasan s. infective	PERSON
ajlm-1807	157	6	indian	NORP
ajlm-1807	160	1	katibi	GPE
ajlm-1807	160	2	bello	ORG
ajlm-1807	161	1	raheem ra	PERSON
ajlm-1807	161	2	nigerian	NORP
ajlm-1807	162	1	niger j	ORG
ajlm-1807	163	1	2020;29(2):261–264	CARDINAL
ajlm-1807	163	2	iregbu kc	PERSON
ajlm-1807	163	3	babaniyi ib	PERSON
ajlm-1807	163	4	nigeria	GPE
ajlm-1807	164	1	afr health sci	ORG
ajlm-1807	166	1	njokanma f	PERSON
ajlm-1807	166	2	ojo o	PERSON
ajlm-1807	168	1	2013;16:1–8.	DATE
ajlm-1807	169	1	nahid ma	PERSON
ajlm-1807	169	2	sami ab	PERSON
ajlm-1807	170	1	dhaka	GPE
ajlm-1807	170	2	bangladesh	GPE
ajlm-1807	170	3	2005–2014	CARDINAL
ajlm-1807	171	1	antimicrob	PERSON
ajlm-1807	172	1	2017;6:2	CARDINAL
ajlm-1807	173	1	rolston kv	PERSON
ajlm-1807	173	2	yadegarynia	GPE
ajlm-1807	173	3	kontoyiannis	NORP
ajlm-1807	173	4	raad ii	PERSON
ajlm-1807	173	5	ho	PERSON
ajlm-1807	174	1	gram	CARDINAL
ajlm-1807	174	2	gram	CARDINAL
ajlm-1807	177	1	https://doi.org/10.1016/j.ijid.2005.05.007 rani nv	PERSON
ajlm-1807	177	2	gopal k	PERSON
ajlm-1807	182	1	2012	DATE
ajlm-1807	183	1	2021	CARDINAL
ajlm-1807	183	2	aug 16];4:543–548	DATE
ajlm-1807	183	3	corpus	PERSON
ajlm-1807	185	1	jureen	PERSON
ajlm-1807	185	2	urassa w	PERSON
ajlm-1807	185	3	tanzania	GPE
ajlm-1807	186	1	bmc infect dis. 2005;5:86	ORG
ajlm-1807	187	1	vardakas kz	PERSON
ajlm-1807	187	2	tansarli gs	PERSON
ajlm-1807	189	1	j antimicrob	PERSON
ajlm-1807	192	1	carbapenem	PERSON
ajlm-1807	193	1	med sci	ORG
ajlm-1807	194	1	2017;6:1	CARDINAL
ajlm-1807	195	1	https://doi.org/10.3390/medsci6010001 howard	PERSON
ajlm-1807	197	1	clin infect dis	ORG
ajlm-1807	198	1	2003;36(suppl_1):s4	CARDINAL
ajlm-1807	200	1	jadhav s	PERSON
ajlm-1807	200	2	paul r	PERSON
ajlm-1807	200	3	misra rn	ORG
ajlm-1807	200	4	india	GPE
ajlm-1807	201	1	sci	ORG
ajlm-1807	203	1	2012	DATE
ajlm-1807	204	1	2021	CARDINAL
ajlm-1807	204	2	sept 22];3(4):1100–1108	DATE
ajlm-1807	205	1	https://www.researchgate.net/publication/286817962 collee	PERSON
ajlm-1807	205	2	j.g.	PERSON
ajlm-1807	205	3	miles	PERSON
ajlm-1807	205	4	r.s.	PERSON
ajlm-1807	206	1	collee	PERSON
ajlm-1807	206	2	j.g.	PERSON
ajlm-1807	206	3	b.p.	GPE
ajlm-1807	206	4	fraser	GPE
ajlm-1807	206	5	a.g.	GPE
ajlm-1807	206	6	simmons, a.	ORG
ajlm-1807	206	7	mackie & mccartney practical medical microbiology	ORG
ajlm-1807	206	8	14th	ORDINAL
ajlm-1807	206	9	churchill livingstone	PERSON
ajlm-1807	206	10	new york	GPE
ajlm-1807	206	11	1996	DATE
ajlm-1807	206	12	131–151	CARDINAL
ajlm-1807	208	1	twenty-fourth	CARDINAL
ajlm-1807	210	1	clsi	PERSON
ajlm-1807	210	2	2014	DATE
ajlm-1807	211	1	2021	CARDINAL
ajlm-1807	211	2	sept 26	DATE
ajlm-1807	212	1	deku jg	PERSON
ajlm-1807	212	2	dakorah mp	PERSON
ajlm-1807	212	3	lokpo sy	PERSON
ajlm-1807	213	1	nine-year	DATE
ajlm-1807	213	2	st. dominic hospital	ORG
ajlm-1807	213	3	akwatia	GPE
ajlm-1807	213	4	ghana	GPE
ajlm-1807	215	1	2019;2019:6750864	CARDINAL
ajlm-1807	216	1	https://doi.org/10.1155/2019/6750864 gupta s	PERSON
ajlm-1807	216	2	kashyap b.	PERSON
ajlm-1807	216	3	north india	LOC
ajlm-1807	217	1	j med res	PERSON
ajlm-1807	219	1	https://doi.org/10.4103/1119-0388.185426 khanal lk	PERSON
ajlm-1807	221	1	2020	DATE
ajlm-1807	222	1	2021 nov 28];10(8):10–14	DATE
ajlm-1807	223	1	https://www.ijhsr.org/ijhsr_vol.10_issue.8_a_aug2020/3.pdf	CARDINAL
ajlm-1807	223	2	south east	LOC
ajlm-1807	223	3	ethiopia	GPE
ajlm-1807	224	1	ethiop j health sci	PERSON
ajlm-1807	226	1	shehab el-din	PERSON
ajlm-1807	226	2	bassiouny	PERSON
ajlm-1807	226	3	hassan r.	PERSON
ajlm-1807	226	4	egypt	GPE
ajlm-1807	229	1	https://doi.org/10.1155/2015/509484 lee	PERSON
ajlm-1807	229	2	mirrett s	ORG
ajlm-1807	230	1	weinstein mp	PERSON
ajlm-1807	231	1	j clin microbiol	PERSON
ajlm-1807	232	1	2007;45(11):3546–3548	CARDINAL
ajlm-1807	233	1	reddy ea	ORG
ajlm-1807	233	2	shaw av	PERSON
ajlm-1807	233	3	crump ja	PERSON
ajlm-1807	233	4	africa	LOC
ajlm-1807	234	1	lancet	ORG
ajlm-1807	235	1	2010;10(6):417–432	CARDINAL
ajlm-1807	235	2	https://doi.org/10.1016/s1473-3099(10)70072-4 mia ar	PERSON
ajlm-1807	235	3	dhaka	GPE
ajlm-1807	235	4	bangladesh	GPE
ajlm-1807	236	1	sci med	ORG
ajlm-1807	237	1	2020;4(1):1–5	CARDINAL
ajlm-1807	238	1	sangita km	PERSON
ajlm-1807	238	2	saha nk	PERSON
ajlm-1807	239	1	sci innov	PERSON
ajlm-1807	240	1	cadirci e	PERSON
ajlm-1807	240	2	halici z. sepsis	PERSON
ajlm-1807	241	1	eurasian	NORP
ajlm-1807	243	1	martins gs	PERSON
ajlm-1807	245	1	2012;10(6):701–706	CARDINAL